Weekly Update of Drug News-23/12/2024

Weekly update of drug news.

Updated on: December 27,2024

Weekly Update of Drug News-23/12/2024

Weekly update of drug news.

Updated on:December 27,2024

Can the flu shot help fight cancer?

byRush University Medical CenterCredit: CC0 Public DomainChanging the microenvironment of tumors to increase the immune system's response to them has been the goal of countless research and

Updated on: December 20,2023

Can the flu shot help fight cancer?

byRush University Medical CenterCredit: CC0 Public DomainChanging the microenvironment of tumors to increase the immune system's response to them has been the goal of countless research and

Updated on:December 20,2023

Out-of-pocket costs for cancer care keep climbing

Cancerpatients already have a lot to deal with emotionally and physically. But research shows that insured patients under 65 are also paying more for their treatments out-of-pocket than ever bef

Updated on: December 18,2023

Out-of-pocket costs for cancer care keep climbing

Cancerpatients already have a lot to deal with emotionally and physically. But research shows that insured patients under 65 are also paying more for their treatments out-of-pocket than ever bef

Updated on:December 18,2023

To improve a promising cancer drug, cut it in half

by Ian Haydon,University of Washington School of MedicineNeoleukin-2/15 can be split into two fragments that reconstitute its activity when combined. a, Splitting strategy for Neo-2/15. Structur

Updated on: January 08,2024

To improve a promising cancer drug, cut it in half

by Ian Haydon,University of Washington School of MedicineNeoleukin-2/15 can be split into two fragments that reconstitute its activity when combined. a, Splitting strategy for Neo-2/15. Structur

Updated on:January 08,2024

Scalp Cooling for Chemo Hair Loss Strikes Out With Patients

M. Alexander Otto, PA, MMSTOPLINE:Most women withbreast cancerwho received scalp cooling did not perceive benefits in preventing hair loss, overall quality of life, body image, and other o

Updated on: October 26,2023

Scalp Cooling for Chemo Hair Loss Strikes Out With Patients

M. Alexander Otto, PA, MMSTOPLINE:Most women withbreast cancerwho received scalp cooling did not perceive benefits in preventing hair loss, overall quality of life, body image, and other o

Updated on:October 26,2023

Tumor Profiling Studies Illuminate Nuances Across Malignancies

November 21, 2022Megan HollaschMolecular and immune landscapes for solid tumors are constantly evolving as precision medicine techniques become more sensitive and next-generation sequencing methods ar

Updated on: October 17,2023

Tumor Profiling Studies Illuminate Nuances Across Malignancies

November 21, 2022Megan HollaschMolecular and immune landscapes for solid tumors are constantly evolving as precision medicine techniques become more sensitive and next-generation sequencing methods ar

Updated on:October 17,2023

Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainCompared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy—given before an

Updated on: October 23,2023

Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainCompared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy—given before an

Updated on:October 23,2023

FDA approves CAR T cell treatment for resistant mantle cell lymphoma

by Jim Stallard,Memorial Sloan Kettering Cancer CenterCredit: Pixabay/CC0 Public DomainMantle cell lymphoma (MCL) is a rare and sometimes ruthless form of non-Hodgkin lymphoma. Even when treatme

Updated on: August 27,2024

FDA approves CAR T cell treatment for resistant mantle cell lymphoma

by Jim Stallard,Memorial Sloan Kettering Cancer CenterCredit: Pixabay/CC0 Public DomainMantle cell lymphoma (MCL) is a rare and sometimes ruthless form of non-Hodgkin lymphoma. Even when treatme

Updated on:August 27,2024

DetermaIO Assay Helps Inform Benefit With Single-Agent Immunotherapy in Advanced NSCLC

November 22, 2022Caroline SeymourThe score of the 27-gene Determa immune-oncology assay demonstrated a correlation with overall survival and progression-free survival in patients with advanced non–sma

Updated on: October 17,2023

DetermaIO Assay Helps Inform Benefit With Single-Agent Immunotherapy in Advanced NSCLC

November 22, 2022Caroline SeymourThe score of the 27-gene Determa immune-oncology assay demonstrated a correlation with overall survival and progression-free survival in patients with advanced non–sma

Updated on:October 17,2023

Real-World Data Highlight Utility of Axi-Cel/Tisa-Cel in DLBCL

June 12, 2021Conor KillmurrayIn the first few years of their availability in the United States, axicabtagene ciloleucel and tisagenlecleucel have been used to mostly treat patients with diffuse large

Updated on: October 24,2023

Real-World Data Highlight Utility of Axi-Cel/Tisa-Cel in DLBCL

June 12, 2021Conor KillmurrayIn the first few years of their availability in the United States, axicabtagene ciloleucel and tisagenlecleucel have been used to mostly treat patients with diffuse large

Updated on:October 24,2023

Uprooting cancer: Hydrogel rapidly reverts cancer cells back to cancer stem cells

A hydrogel developed at Hokkaido University successfully reverted cancer cells back to cancer stem cells within 24 hours in six different human cancer types. This could lead to the development of anti

Updated on: November 02,2023

Uprooting cancer: Hydrogel rapidly reverts cancer cells back to cancer stem cells

A hydrogel developed at Hokkaido University successfully reverted cancer cells back to cancer stem cells within 24 hours in six different human cancer types. This could lead to the development of anti

Updated on:November 02,2023

A new mechanism of drug resistance discovered for breast cancer

by Universita Cattolica del Sacro CuoreEmergence of CSCs following IFN-I treatment.a, Multiparametric flow cytometry analysis of the illustrated CSC surface markers in MCA205 and AT3 cells treat

Updated on: December 21,2023

A new mechanism of drug resistance discovered for breast cancer

by Universita Cattolica del Sacro CuoreEmergence of CSCs following IFN-I treatment.a, Multiparametric flow cytometry analysis of the illustrated CSC surface markers in MCA205 and AT3 cells treat

Updated on:December 21,2023